➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Boehringer Ingelheim
McKinsey
Dow
Express Scripts

Last Updated: October 1, 2020

DrugPatentWatch Database Preview

Patent: 8,491,917

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,491,917
Title:Treatment of migraine headache with diffusion of toxin in non-muscle related areas of the head
Abstract: A method for treating a patient with migraine headache in accordance with the present invention generally includes administering to the patient a therapeutically effective amount of a Botulinum toxin in a pharmaceutically safe form with the administration being on the trigeminal cervical system, for enabling axonal transport of the neurotoxin from distal to central sites. More specifically, the administration includes extramuscular injection of the neurotoxin over the aponeurotic fascia of the scalp for enabling the neurotoxin to diffuse into distal sensory nerves, in order to enable concentration over the occipital-parietal-frontal head region.
Inventor(s): Bender; William J. (Beverly Hills, CA)
Assignee:
Application Number:13/478,876
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,491,917
Patent Claims:see list of patent claims

Details for Patent 8,491,917

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Allergan BOTOX COSMETIC onabotulinumtoxina VIAL; SINGLE-USE 103000 005 1991-12-09   Start Trial 2032-03-12 RX search
Allergan BOTOX COSMETIC onabotulinumtoxina VIAL; SINGLE-USE 103000 004 1991-12-09   Start Trial 2032-03-12 RX search
Allergan BOTOX onabotulinumtoxina VIAL; SINGLE-USE 103000 003 1991-12-09   Start Trial 2032-03-12 RX search
Allergan BOTOX onabotulinumtoxina VIAL; SINGLE-USE 103000 002 1991-12-09   Start Trial 2032-03-12 RX search
Allergan BOTOX onabotulinumtoxina VIAL; SINGLE-USE 103000 001 1991-12-09   Start Trial 2032-03-12 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 8,491,917

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Colorcon
McKesson
Merck
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.